{"id":"W2598071611","doi":"10.1200/jco.2017.35.6_suppl.492","title":"Real world experience of immuno-oncology agents in metastatic renal cell carcinoma: Results from the IMDC.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre; University of Alberta; Université de Montréal; Queen Elizabeth II Health Sciences Centre; McMaster University; London Health Sciences Centre; University of Calgary","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Avelumab; Pembrolizumab; Atezolizumab; Renal cell carcinoma; Internal medicine; Oncology; Population; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005334285,0.0003831606,0.0004884355,0.0006368606,0.0003637123,0.001381767,0.0005457433,0.0005898623,0.00106913],"category_scores_gemma":[0.008376048,0.0001712414,0.0006015322,0.001505493,0.0003575156,0.0006598042,0.0008679277,0.0005171172,0.0005724121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00150738,"about_ca_system_score_gemma":0.0009873323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005695237,"about_ca_topic_score_gemma":0.005127043,"domain_scores_codex":[0.9967404,0.00162205,0.0003771198,0.0003246422,0.0007023374,0.0002334825],"domain_scores_gemma":[0.9904566,0.00246783,0.003510892,0.0006234872,0.001724397,0.001216765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004663172,0.001186847,0.9100845,0.0005449534,0.0003855438,0.0007150272,0.0007968634,0.001868087,0.0008174177,0.0001342196,0.006859288,0.07194412],"study_design_scores_gemma":[0.001407458,0.01043352,0.9272367,0.0003899958,0.0009601603,0.004775684,0.001456533,0.002977399,0.00316596,0.0001087761,0.04699031,0.00009751481],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9677497,0.01674912,0.0007460017,0.0009325836,0.00005994481,0.0002074897,0.009166939,0.00002964326,0.004358556],"genre_scores_gemma":[0.9847231,0.004546082,0.0007945382,0.0006548921,0.000116825,0.00008841119,0.008366378,0.00001696252,0.000692814],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005695237,"threshold_uncertainty_score":0.02821076,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2582689320801057,"score_gpt":0.4875456563478964,"score_spread":0.2292767242677907,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}